cyclosporine 1 MG/ML Ophthalmic Suspension [Verkazia]
- RxCUI
- 2590613
- RxNorm name
- cyclosporine 1 MG/ML Ophthalmic Suspension [Verkazia]
- Display name
- cyclosporine 1 MG/ML Ophthalmic Suspension [Verkazia]
- Full name
- cyclosporine 1 MG/ML Ophthalmic Suspension [Verkazia]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Verkazia | CYCLOSPORINE | Harrow Eye, LLC | 48651d30-9e6e-74b0-e063-6294a90a8337 | 2026-06-03 | Warnings, Adverse reactions | 2590613 |
| Verkazia | CYCLOSPORINE | Santen Incorporated | c795cd2f-89da-78e3-e053-2a95a90a9422 | 2025-01-17 | Warnings, Adverse reactions | 2590613 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c795cd2f-89da-78e3-e053-2a95a90a9422 | Verkazia 0.1 % Ophthalmic Suspension [PSN] · cyclosporine 1 MG/ML Ophthalmic Suspension [Verkazia] [SBD] · Verkazia 1 MG/ML Ophthalmic Suspension [SY] | 3 | 6 | These highlights do not include all the information needed to use VERKAZIA safely and effectively. See full prescribing information for VERKAZIA. Verkazia® (cyclosporine ophthalmic emulsion) 0.1%, for topical ophthalmic use Initial U.S. Approval: 1983 | 20250117 |
| 48651d30-9e6e-74b0-e063-6294a90a8337 | Verkazia 0.1 % Ophthalmic Suspension [PSN] · cyclosporine 1 MG/ML Ophthalmic Suspension [Verkazia] [SBD] · Verkazia 1 MG/ML Ophthalmic Suspension [SY] | 3 | 4 | These highlights do not include all the information needed to use VERKAZIA safely and effectively. See full prescribing information for VERKAZIA. Verkazia® (cyclosporine ophthalmic emulsion) 0.1%, for topical ophthalmic use Initial U.S. Approval: 1983 | 20260324 |